Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Archives
Recent-posts
How to Store Controlled Substances to Prevent Diversion: A Practical Guide for Healthcare Facilities
Nov, 16 2025

Medications